Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

pEB-C5 Citations (6)

Plasmid Article: Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.
Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM, Zou C, Zhang YA, Tong J, Cheng L Cell Res. 2011 Jan 18. ():.
PubMed Journal

Articles Citing pEB-C5

Articles
Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Dowey SN, Huang X, Chou BK, Ye Z, Cheng L. Nat Protoc. 2012 Nov;7(11):2013-21. doi: 10.1038/nprot.2012.121. Epub 2012 Oct 18. PubMed
An Efficient Non-viral Method to Generate Integration-Free Human iPS Cells from Cord Blood and Peripheral Blood Cells. Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, Goshima N, Yamanaka S. Stem Cells. 2012 Nov 29. doi: 10.1002/stem.1293. PubMed

Associated Plasmids

Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells. Ye Z, Liu CF, Lanikova L, Dowey SN, He C, Huang X, Brodsky RA, Spivak JL, Prchal JT, Cheng L. Stem Cells. 2014 Jan;32(1):269-78. doi: 10.1002/stem.1545. PubMed
Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling. Sivapatham R, Zeng X. Methods Mol Biol. 2014 Dec 18. PubMed
KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Kim SI, Oceguera-Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, Yamamoto T, Yamanaka S, Woltjen K. Stem Cell Reports. 2015 Apr 14;4(4):727-43. doi: 10.1016/j.stemcr.2015.02.004. Epub 2015 Mar 12. PubMed

Associated Plasmids

Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity. Khoshchehreh R, Totonchi M, Carlos Ramirez J, Torres R, Baharvand H, Aicher A, Ebrahimi M, Heeschen C. Oncogene. 2019 Aug;38(34):6226-6239. doi: 10.1038/s41388-019-0871-x. Epub 2019 Jul 15. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.